Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma. (Q53243267)

12 May 2018

title

Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma. (English)

1 reference

12 May 2018

4

Kari Syrjänen

1 reference

12 May 2018

author name string

Jaudah Al-Maghrabi

1

1 reference

12 May 2018

Mahmoud Al-Ahwal

2

1 reference

12 May 2018

Abdelbaset Buhmeida

3

1 reference

12 May 2018

Abdulrahman Sibyani

5

1 reference

12 May 2018

Eman Emam

6

1 reference

12 May 2018

Ayman Ghanim

7

1 reference

12 May 2018

Mohmmad Al-Qahtani

8

1 reference

12 May 2018

publication date

1 June 2012

1 reference

12 May 2018

Journal of gastrointestinal cancer

published in

1 reference

12 May 2018

volume

43

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

279-287

1 reference

12 May 2018

Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Modulation of cell cycle components by epigenetic and genetic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

The ubiquitin-proteasome pathway and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

p27 Protein and cancers of the gastrointestinal tract and liver: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Cyclin E and survival in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Prognostic impact of Skp2 and p27 in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Role of p27 in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Adjuvant chemotherapy in colon cancer: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Surgical therapy for colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Follow-up after curative resection of colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Correlation of nuclear morphometry and DNA ploidy in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Colorectal cancer proteomics, molecular characterization and biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

The prognostic value of p27 in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-011-9292-Y

Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer

21 January 2018

1 reference

12 December 2020

MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases

1 reference

12 December 2020

Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer

1 reference

12 December 2020

DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.

1 reference

12 December 2020

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer

1 reference

12 December 2020

[Relationship between expression of p27 and DNA ploidy in colorectal carcinoma]

1 reference

12 December 2020

Molecular prognostic factors in rectal cancer

1 reference

12 December 2020

Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization

1 reference

12 December 2020

Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas

1 reference

12 December 2020

p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation

1 reference

12 December 2020

Colorectal cancer screening in evolution: Japan and the USA

1 reference

12 December 2020

p53 and p27 gene expression in subserosal gallbladder carcinoma

1 reference

12 December 2020

Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas

1 reference

12 December 2020

Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis

1 reference

12 December 2020

Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer

1 reference

12 December 2020

[Expression of cycline-dependent kinase p27 in the low differentiated gastric adenocarcinoma]

1 reference

12 December 2020

Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer

1 reference

12 December 2020

Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.

1 reference

12 December 2020

10.1007/S12029-011-9292-Y

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018